News for 'oxford-university'

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Rediff.com3 Aug 2020

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

Brazil's COVID vaccine volunteer dies, tests to continue

Brazil's COVID vaccine volunteer dies, tests to continue

Rediff.com22 Oct 2020

While it is not clear whether the volunteer had received the vaccine or a placebo shot during the trial, Anvisa has refused to reveal any more information citing reasons of medical privacy, CNN reported.

Covid Lockdown: How India Fared

Covid Lockdown: How India Fared

Rediff.com1 Apr 2023

The March 2020 lockdown did not stop the spread of infection (as it triggered a huge reverse migration from cities), but it did help to flatten the curve and gave time to scale up health infrastructure.

Serum chief 'hopes to resolve' EU ban on Covishield recipients

Serum chief 'hopes to resolve' EU ban on Covishield recipients

Rediff.com28 Jun 2021

"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.

Oxford vaccine safe, Indian trials going on smoothly: Serum Institute

Oxford vaccine safe, Indian trials going on smoothly: Serum Institute

Rediff.com26 Nov 2020

The comments came after AstraZeneca and Oxford University acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.

Will raise racism with UK when required: Govt

Will raise racism with UK when required: Govt

Rediff.com15 Mar 2021

India will take up with the United Kingdom when required the alleged incidents of racism in Britain, External Affairs Minister S Jaishankar said in the Rajya Sabha on Monday. He also described India as the land of Mahatma Gandhi and said it can never turn its eyes away from racism.

India 'Stay Calm' About Kraken: Experts

India 'Stay Calm' About Kraken: Experts

Rediff.com16 Jan 2023

The Kraken COVID-19 variant accounts for almost 41 per cent of all Covid infections.

As British MP Rishi Sunak took oath on Bhagavad Gita

As British MP Rishi Sunak took oath on Bhagavad Gita

Rediff.com24 Oct 2022

Here are some facts about Rishi Sunak and his India connections.

Eminent economist Isher Judge Ahluwalia passes away

Eminent economist Isher Judge Ahluwalia passes away

Rediff.com26 Sep 2020

Her research was focused on urban development, macro-economic reforms, industrial development, and social sector development issues in India.

France to allow travellers vaccinated with Covishield

France to allow travellers vaccinated with Covishield

Rediff.com19 Jul 2021

"The vaccination schedule is considered complete 28 days after the administration of a dose for Janssen vaccine and 7 days after administration of a second dose for other vaccines (Pfizer / Comirnaty, Moderna, AstraZeneca/Vaxzevria/Covishield)," the statement added.

Dom's Take: COVID-19 vaccine: So close, yet so far

Dom's Take: COVID-19 vaccine: So close, yet so far

Rediff.com3 Aug 2020

Dominic Xavier offers his take on the COVID-19 vaccine which experts feel should be expected in mid-2021 only. Till then we have to get used to live with the virus.

Sofia Hayat's bikini pose

Sofia Hayat's bikini pose

Rediff.com6 Jun 2014

Here's what your favourite Bollywood celebrities are tweeting.

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

G20 leaders agree to strengthen WHO to fast-track EUA for Covid vax: Goyal

G20 leaders agree to strengthen WHO to fast-track EUA for Covid vax: Goyal

Rediff.com31 Oct 2021

Briefing the media in Rome, Goyal said the Leaders adopted the 'Rome Declaration' at the G20 Summit and the communique gives a very strong message under the health section with the countries agreeing that the COVID-19 immunisation is a global public good.

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

Serum seeks emergency use for its COVID-19 vaccine

Serum seeks emergency use for its COVID-19 vaccine

Rediff.com7 Dec 2020

SII is the first indigenous company that has sought emergency approval for the vaccine developed along with global pharma giant AstraZeneca and Oxford University.

UK hospital told to prep for COVID vaccine by Nov: Report

UK hospital told to prep for COVID vaccine by Nov: Report

Rediff.com26 Oct 2020

The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus.

Phase 3 clinical trial of Oxford vaccine begins in Pune

Phase 3 clinical trial of Oxford vaccine begins in Pune

Rediff.com21 Sep 2020

"We have started the phase-III trials of the vaccine (candidate Covishield). We will administer dose to 150 to 200 volunteers," said Dr Muralidhar Tambe, Dean, Sassoon General Hospital.

J&J in talks with India for study of single-dose vaccine

J&J in talks with India for study of single-dose vaccine

Rediff.com9 Apr 2021

India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.

Incident with volunteer no way induced by vaccine: Serum Institute

Incident with volunteer no way induced by vaccine: Serum Institute

Rediff.com1 Dec 2020

A Chennai-based man has demanded a compensation of Rs 5 crore from the SII after his health worsened allegedly after volunteering for the clinical trials for a COVID-19 vaccine.

New Covid strains may lead to spike in hospitalisation, fear experts

New Covid strains may lead to spike in hospitalisation, fear experts

Rediff.com27 Oct 2022

An immune-escape Covid-19 strain coupled with the natural spike in influenza and pneumonia cases during winters may lead to a rise in hospitalisation.

Serum Institute to begin trials of COVID-19 vaccine in Mumbai, Pune

Serum Institute to begin trials of COVID-19 vaccine in Mumbai, Pune

Rediff.com23 Jul 2020

There are a number of trial sites across both Mumbai and Pune that we have shortlisted, as these cities have many hotspots, which will help us understand the efficacy of the vaccine, the company's chief executive Adar Poonawalla said.

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

Rediff.com22 Jul 2020

Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.

Foreign secy visit Bangladesh, meets PM Sheikh Hasina

Foreign secy visit Bangladesh, meets PM Sheikh Hasina

Rediff.com18 Aug 2020

Shringla visited Dhaka in March last after assuming office of the Indian Foreign Secretary in January this year.

Indians may not get to choose which vaccine shot to get

Indians may not get to choose which vaccine shot to get

Rediff.com12 Jan 2021

Replying to a question at a press conference in New Delhi, Union Health Secretary Rajesh Bhushan said, "At many places in the world, more than one vaccine are being administered, but presently, in no country, vaccine recipients have the option of choosing the shots."

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Rediff.com12 Sep 2020

AstraZeneca and the University of Oxford, as the trial sponsor, said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.

Narayana Murthy's son-in-law named UK finance minister

Narayana Murthy's son-in-law named UK finance minister

Rediff.com14 Feb 2020

The MP for Richmond in Yorkshire, married to Murthy's daughter Akshata, first entered the UK Parliament in 2015 and has fast risen up the Conservative Party ranks as a staunch Brexiteer who had back Johnson's strategy to leave the European Union.

Modi's khaas dost Johnson set India-UK ties on comprehensive course

Modi's khaas dost Johnson set India-UK ties on comprehensive course

Rediff.com7 Jul 2022

His visit to India followed a few cancelled plans since he took office in July 2019 due to the coronavirus pandemic crisis, with the two leaders holding several virtual talks and eventually meeting in person on the sidelines of the COP26 climate summit in Glasgow last November.

PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

Rediff.com27 Nov 2020

On Tuesday, Rao said there was a possibility of the PM's visit to Pune, and if that happens, it would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms.

WHO nod for Covaxin expected any time now

WHO nod for Covaxin expected any time now

Rediff.com26 Oct 2021

A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its decision within the next 24 hours or so, a spokesperson said.

Mixing COVID-19 vaccines gives good protection: Study

Mixing COVID-19 vaccines gives good protection: Study

Rediff.com29 Jun 2021

According to the study, 'mixed' schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart.

India trade deal eludes another British prime minister

India trade deal eludes another British prime minister

Rediff.com20 Oct 2022

Britain's third female prime Minister, Liz Truss, was out of office on Thursday after the shortest tenure at 10 Downing Street in London and without a cherished India-UK free trade agreement (FTA) under her belt as a Brexit prize.

Nirav Modi 'only thinks of cutting or hanging if extradited'

Nirav Modi 'only thinks of cutting or hanging if extradited'

Rediff.com11 Oct 2022

The high court in London on Tuesday began hearing evidence from two leading experts in the field of psychiatry to determine the level of suicide risk faced by Nirav Modi if he is extradited to India to face charges of fraud and money laundering, amounting to an estimated $2 billion in the Punjab National Bank (PNB) loan scam case. Lord Justice Jeremy Stuart-Smith and Justice Robert Jay heard from Andrew Forrester, Professor of Forensic Psychiatry at Cardiff University, and Seena Fazel, Professor of Forensic Psychiatry at Oxford University, in the final stages of the extradition appeal being pursued by the 51-year-old diamond merchant. The two psychiatrists weighed up Nirav's level of depression, which could pose a "substantial" or "elevated" risk of suicide.

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

Rediff.com30 Dec 2020

The UK's National Health Service was already lining up thousands of medics and volunteers to be ready to deliver jabs up and down the country.

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Rediff.com19 Sep 2020

"The phase-III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. "Around 150 to 200 volunteers will be administered the vaccine candidate dose," Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe said.

'India and China to dominate this century'

'India and China to dominate this century'

Rediff.com27 Sep 2011

There has been a major shift in the global balance of economic power, creating a new global hierarchy dominated by the East, says Chris Patten, chancellor of Oxford University. Naomi Canton reports.

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Rediff.com19 Aug 2020

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.

Historic! Rishi Sunak to be UK's 1st Indian-origin PM

Historic! Rishi Sunak to be UK's 1st Indian-origin PM

Rediff.com24 Oct 2022

Rishi Sunak on Monday is all set to make history on Diwali as Britain's first Indian-origin prime minister after being elected unopposed as the new leader of the governing Conservative Party, following Penny Mordaunt's withdrawal from the race.

Rishi Sunak likely to become first Indian-origin British PM today

Rishi Sunak likely to become first Indian-origin British PM today

Rediff.com24 Oct 2022

With the former prime minister stepping aside on Sunday night saying it was "simply not the right time" for his comeback, the prospect of a Diwali victory for Sunak cannot be ruled out.

UK's PM-in-waiting Liz Truss remains committed to India ties

UK's PM-in-waiting Liz Truss remains committed to India ties

Rediff.com5 Sep 2022

Newly-elected Conservative Party leader and prime minister in waiting Liz Truss is among the senior British politicians known for championing deeper India-UK strategic and economic ties, describing them as a "sweet spot" of global trade dynamics.